Twist Bioscience (TWST) Long-Term Investments (2021 - 2026)

Twist Bioscience (TWST) has reported Long-Term Investments for 5 consecutive years, with $68.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Long-Term Investments changed N/A year-over-year to $68.1 million; the TTM figure through Mar 2026 stood at $68.1 million (changed N/A YoY), while the FY2025 annual figure was $54.3 million, up 3463.08% from the prior year.
• Long-Term Investments advanced to $68.1 million in Q1 2026 per TWST's latest filing, from $54.3 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $68.1 million in Q1 2026 and bottomed at $1.5 million in Q3 2024.
• Historically, Long-Term Investments has averaged $43.9 million across 4 years, with a median of $54.3 million in 2025.
• On a YoY basis, Long-Term Investments climbed as much as 3463.08% in 2025 and fell as far as 3463.08% in 2025.
• Twist Bioscience's Long-Term Investments stood at $30.6 million in 2022, then slumped by 95.01% to $1.5 million in 2024, then jumped by 3463.08% to $54.3 million in 2025, then climbed by 25.31% to $68.1 million in 2026.
• Business Quant data shows TWST's Long-Term Investments at $68.1 million in Q1 2026, $54.3 million in Q4 2025, and $54.3 million in Q3 2025.